Neogen Corporation (NEOG) recently announced the launch of its new Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96). This assay helps overcome certain limitations of existing solutions with improved sensitivity and accuracy and an easy-to-use workflow.Molecular Detection Assay 2 - Quantitative Salmonella is the latest addition to the company’s Molecular Detection System pathogen testing platform.NEOG’s Likely Stock Trend Following the NewsFollowing the announcement, shares of NEOG m ...

LANSING, Mich., Jan. 16, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the launch of the new Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96).The Neogen MDA2QSAL96 kit integrates qualitative pathogen testing solutions and Quantitative Rapid Enrichment Dehydrated (QRED) media designed to enable controlled growth rates for quantitation, allowing poultry producers to verify the effectiveness of their intervention ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) (Exact name of registrant as specified in its charter) Michigan 38-2367843 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification Number) 620 Lesher Place Commission file number 0-17988 Lansing, Michigan 48912 (Address of principal executive offices, including zip code) Neogen Corporation or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 193 ...

Neogen Corporation (NEOG) reported preliminary second-quarter fiscal 2025 adjusted earnings per share (EPS) of 11 cents, in line with the Zacks Consensus Estimate. The bottom line was also on par with the year-ago quarter’s registered numbers.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the preliminary earnings announcement, NEOG stock fell 5.4% to $12.36 last Friday.Neogen’s Q2 RevenuesAs per the preliminary results, revenues surged 0.7% on a year-over-year basis to $231 ...

Neogen Corporation (NASDAQ:NEOG) Q2 2025 Earnings Conference Call January 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations John Adent - Chief Executive Officer and President David Naemura - Chief Financial Officer Conference Call Participants Brandon Vazquez - William Blair Subbu Nambi - Guggenheim Securities David Westenberg - Piper Sandler Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation Second Qu ...

Neogen (NEOG) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this maker of medical testing kits would post earnings of $0.10 per share when it actually produced earnings of $0.07, delivering a surprise of -30%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.Neogen, which b ...

Exhibit 99.1 Neogen Announces Preliminary 1 Second-Quarter 2025 Results 1 Results presented in this release are preliminary and unaudited estimates based on information currently available to the Company. Such results could differ from the final amounts the Company reports in its Quarterly Report on Form 10-Q for the fiscal quarter ended November 30, 2024. The Company assumes no obligation, and does not intend, to update these estimates prior to filing its Form 10-Q. 2 Non-GAAP financial measures; see expla ...

Revenue of $231.3 million. Net loss of $456.3 million due to non-cash goodwill impairment; $(2.10) per diluted share. Adjusted Net Income2 of $24.4 million; $0.11 per diluted share. Adjusted EBITDA2 of $51.4 million. Updating full-year guidance.LANSING, Mich., Jan. 10, 2025 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today the preliminary results of the second quarter ended November 30, 2024."The second quarter reflected steady progress, as we saw improvement across the business compared to ...

LANSING, Mich., Jan. 7, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in two upcoming investor conferences. The Company will participate in the CJS Securities 25th Annual Investor Conference, held virtually on January 14, 2025. John Adent, Neogen's President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on January 15, 2025, at 3:45 PM PT. To access the webcast and presentation materials for ...

In its upcoming report, Neogen (NEOG) is predicted by Wall Street analysts to post quarterly earnings of $0.11 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $226.37 million, representing a year-over-year decrease of 1.4%.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.P ...